Early Detection of Prostate Cancer Using PDL-1 and IL-6 In Najaf Al-Ashraf Governorate

The current study, collected 240 samples blood divided into first group was a healthy which included man (60) while second group interested patients of prostate cancer from (180) man and by used ELAISA techniques for prognosis prostate cancer by serum parameters programmed cell death-ligand 1 (PDL-1) , Interleukin 6 (IL-6) is an interleukin that acts as both a pro-inflammatory cytokine and an anti-inflammatory myokine. The statistical results of the immune markers (PDL-1, IL-6) when (180) samples collected from patients and (60) healthy showed relationship with cancer when compared with the results of healthy people. It was highly significant and p. Value